Colorectal cancer (CRC) is one of the most frequently diagnosed cancers in the Western world. Differentiated surgical therapy in the last years have made a curative resection possible in more than 80% of the cases. Two hundred ninety consecutive patients with colorectal cancer over 6 years were enrolled in a retrospective follow-up study based on the electronic patient record, with special regard to patients more than 70 years old. The outcome was evaluated using the following endpoints: resectability, 30-days morbidity (local and general complications), mortality, re-operation rate, and survival. The mean age of the 290 patients was 71.5 years; 176 patients were more than 70 years old and the male to female ratio was 148:142. Three hundred eight tumors had been diagnosed in the 290 patients. Tumor staging was as follows: stage I, 18.5%; stage II, 30%; stage III, 32%; and stage IV, 19.5%. A local R0 resection was made possible in 97% of the tumors. The 30-days morbidity incidence for patients younger/older than 70 years was 33%/57% (P < 0.05), the mortality incidence was 2.6%/3.4% (P value not significant), and the reoperation rate was 7.0%/9.1% (P value not significant). Anastomotic leaks occurred in 3.5% of the patients. The 1-, 2-, and 5-year survival rates were 81.4%, 66.3%, and 61.5%, respectively. Our findings show that colorectal carcinomas may be operated with mostly curative intent with a low mortality rate, a high R0 resection rate, and similar complications, mortality, and re-operation rates, even in patients more than 70 years old.

Download full-text PDF

Source

Publication Analysis

Top Keywords

colorectal cancer
12
patients years
12
patients
9
special regard
8
patients colorectal
8
30-days morbidity
8
complications mortality
8
mortality re-operation
8
290 patients
8
years
7

Similar Publications

Extracellular matrix stiffness regulates colorectal cancer progression via HSF4.

J Exp Clin Cancer Res

January 2025

Department of General Surgery, Xiangya Hospital, Central South University, Changsha, Hunan, 410008, China.

Background: Colorectal cancer (CRC) has high incidence and mortality rates, with severe prognoses during invasion and metastasis stages. Despite advancements in diagnostic and therapeutic technologies, the impact of the tumour microenvironment, particularly extracellular matrix (ECM) stiffness, on CRC progression and metastasis is not fully understood.

Methods: This study included 107 CRC patients.

View Article and Find Full Text PDF

Background: Highly frequent colorectal cancer (CRC) is predicted to have 3.2 million novel cases by 2040. Tumor microenvironment (TME) bacteriome and metabolites are proposed to be involved in CRC development.

View Article and Find Full Text PDF

Background: Extraskeletal osteosarcoma (ESOS) is a rare kind of sarcoma with a low preoperative diagnosis and a poor prognosis. ESOS arising from abdominal mesentery is extremely rare. Increasing diagnostic methods and standardizing treatment protocols are crucial issues of ESOS.

View Article and Find Full Text PDF

Background: The risk of developing advanced neoplasia (AN; colorectal cancer and/or high-grade dysplasia) in ulcerative colitis (UC) patients with a low-grade dysplasia (LGD) lesion is variable and difficult to predict. This is a major challenge for effective clinical management.

Objective: We aimed to provide accurate AN risk stratification in UC patients with LGD.

View Article and Find Full Text PDF

Colorectal cancer (CRC), one of the diseases posing a threat to global health, according to the latest data, is the third most common cancer globally and the second leading cause of cancer-related deaths. The development and refinement of novel structures of small molecular compounds play a crucial role in tumor treatment and overcoming drug resistance. In this study, our objective was to screen and characterize novel compounds for overcoming drug resistance via the B Lymphoma Mo-MLV insertion region 1 (Bmi-1) reporter screen assay.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!